Our Treatments

Our Treatments

Treatments

A Platform for Mental Health Treatment

BrainsWay’s treatment platform is based on a unique breakthrough technology called Deep TMS, which can reach significant depth and breadth of the brain and produce broad stimulation and functional modulation of targeted brain areas.

The treatment features unique, patented coils that are fitted into a helmet, which is secured snugly to the patient’s head during the treatment. BrainsWay’s therapy has been utilized in over 60 clinical trials worldwide. In the U.S., the company’s device has been FDA cleared for the treatment of Major Depressive Disorder (MDD) since 2013, FDA cleared (De-Novo) for the treatment of Obsessive Compulsive Disorder (OCD) since 2018, and is now FDA cleared as an aid for short-term Smoking Cessation.

BrainsWay Psychiatric
Treatments

Learn more about how BrainsWay’s innovative technology can be effective in treating psychiatric disorders.

FDA Cleared CE Marked
Major Depressive Disorder (MDD)

Major Depressive Disorder is a neuropsychiatric disorder that is expressed in emotional, physiological and behavioral effects.

FDA Cleared CE Marked
Obsessive Compulsive Disorder (OCD)

BrainsWay Introduces the First FDA Cleared (De-Novo) Non-invasive Medical Device for the Treatment of OCD.

FDA Cleared CE Marked
Smoking Cessation

Tobacco smoking is the leading cause of preventable death in developed countries.

CE Marked Not for commercial use in the US
Bipolar Disorder

Bipolar disorder, also known as manic-depressive illness

CE Marked Not for commercial use in the US
Post Traumatic Stress Disorder

Post-traumatic stress disorder (PTSD) is an extreme anxiety response to a life-threatening situation

CE Marked Not for commercial use in the US
Schizophrenia (Negative Symptoms)

Anti-psychotic medications are often effective for the positive symptoms of schizophrenia

BrainsWay Neurological
Treatments

Learn more about how BrainsWay’s innovative technology can be effective in treating neurological disorders.

CE Marked Not for commercial use in the US
Alzheimer’s Disease Treatment

Alzheimer's disease is a major cause of severe cognitive decline in the aged.

CE Marked Not for commercial use in the US
Autism

Autism is a complex developmental disability that typically appears during the first three years of life

CE Marked Not for commercial use in the US
Chronic Pain

Neuropathy is common in the diabetic population, affecting approximately 50% of patients with long-lasting diseases.

CE Marked Not for commercial use in the US
Multiple Sclerosis (MSC)

Multiple Sclerosis (MSc) is an inflammatory demyelinating condition of the central nervous system

CE Marked Not for commercial use in the US
Parkinson’s Disease

Parkinson's disease is a degenerative disorder of the central nervous system

CE Marked Not for commercial use in the US
Post Stroke Rehabilitation

A brain stroke is the loss of brain function due to a disturbance in the blood supply to the brain.